Retroperitoneal lymph node dissection in clinical stage I non-seminomatous germ cell testicular tumours Long term results in a single-center 16-year experience

Risk of distant metastasis following retroperitoneal lymph-node dissection (RPLND) alone in clinical stage I (CS I) non-seminomatous germ cell testicular tumours (NSGCTTS). Journal of Urology 179(4): 176, 2008

Ongoing study of laparoscopic retroperitoneal lymph-node dissection (L-RPLND) in low risk clinical stage I non seminomatous germ cell testicular tumours (NSGCTT). The Journal of Urology 179(4): 241, 2008

Centralised re-assessment of vascular invasion in clinical stage I (CS 1) non-seminomatous germ-cell testicular tumours (NSGCTTS) submitted to primary retroperitoneal lymph-node dissection (RPLND): Clinical implications. 2008

Long-term results of laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testicular cancer. Journal of Endourology 21(2): 180-183, 2007

Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor?. Urology Journal 10(2): 873-877, 2014

Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience. Urology 63(3): 550-555, 2004

Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: A long-term update. Urology 62(2): 324-327, 2003

Laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell tumour Short term results from a high volume laparoscopy center. European Urology Suppl.s 2(1): 49, 2003

Robot-assisted laparoscopic retroperitoneal lymph node dissection for left clinical stage I non-seminomatous germ cell testicular cancer: focus on port placement and surgical technique. International Journal of Urology 21(2): 212-214, 2014

Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study. Bmc Urology 18(1): 95, 2018

Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence. European Urology 58(6): 912-918, 2011

Clinical stage B non-seminomatous germ cell testis cancer: the Indiana University experience (1965-1989) using routine primary retroperitoneal lymph node dissection. European Journal of Cancer 31A(10): 1599-1604, 1995

Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer: Review of the Indiana University experience 1965-1989. British Journal of Urology 71(3): 326-335, 1993

Laparoscopic Retroperitoneal Lymph-Node Dissection (L-Rplnd): Evolution Towards A Single-Stategy Management In Clinical Stage I (Cs I) Non-Seminomatous Germ-Cell Tumors Of The Testis (Nsgctt). The Journal of Urology 185(4): e392-e393, 2011

Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer. Bju International 109(2): 281-285, 2012